Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors. New England Journal of Medicine. 2006;354(23). doi:10.1056/nejmoa055202.

Save
Print
June 21, 2006
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. New England Journal of Medicine. 2006;354(23).
View more articles from the same authors.
This U.S. Food and Drug Administration (FDA)– and AHRQ–funded study documents the possibility of adverse effects on the fetus when mothers take angiotensin-converting enzyme (ACE) inhibitors during the first trimester of pregnancy.
Save
Print
Cite
Citation

Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors. New England Journal of Medicine. 2006;354(23). doi:10.1056/nejmoa055202.

Related Resources From the Same Author(s)
Related Resources